期刊文献+

缬沙坦联合氨氯地平治疗老年原发性高血压合并糖尿病的疗效观察 被引量:5

Efficacy of Valsartan Combined With Amlodipine in the Treatment of Elderly Patients With Essential Hypertension and Diabetes Mellitus
下载PDF
导出
摘要 目的 探讨缬沙坦联合氨氯地平治疗老年原发性高血压合并糖尿病的疗效。方法 选择我院2013年4月~2015年11月收治的老年原发性高血压合并糖尿病患者80例为研究对象,随机将其分为观察组和对照组,各40例。对照组给予氨氯地平,观察组给予缬沙坦联合氨氯地平治疗。比较两组治疗效果。结果 治疗后,观察组患者血压下降趋势高于对照组,观察组患者微量尿白蛋白排泄率及24 h蛋白定量均低于对照组,差异有统计学意义(P〈0.05)。结论 缬沙坦联合氨氯地平治疗老年原发性高血压合并糖尿病的临床效果显著,有助于改善血压水平。 Objective To discuss the effect of agedness with essential hypertension complicated diabetes mellitus treated by valsartan combines amlodipine. Methods 80 cases of ageneses patients with essential hypertension complicated diabetes mellitus were selected in our hospital from the April 2013 to November 2015 as the object of study, to randomly divided into the treatment group and control group, 40 cases in each group. The control group received amlodipine, valsartan combined observation group amlodipine treatment. To compared the treatment effect of them. Results After treatment, the blood pressure of patients in the observation group decreased significantly higher in the observation group were micro urinary albumin excretion rate and 24 h protein excretion were lower than the control group, the difference was significant(P0.05). Conclusion That has significant clinical effect of agedness with essential hypertension complicated diabetes mellitus treated by valsartan combines amlodipine, and help for improving the blood pressure level.
作者 谭子凯
出处 《中国继续医学教育》 2016年第22期171-172,共2页 China Continuing Medical Education
关键词 缬沙坦 氨氯地平 原发性高血压 糖尿病 Valsartan Amlodipine Primary hypertension Diabetes
  • 相关文献

参考文献9

二级参考文献85

  • 1罗明,袁春梅,蒋彦,吕群英.缬沙坦治疗原发性高血压72例疗效观察[J].中国继续医学教育,2013,5(1):7-8. 被引量:5
  • 2吴兆苏,霍勇,王文,赵连友,朱鼎良.中国高血压患者教育指南[J].中国医学前沿杂志(电子版),2014,6(3):78-109. 被引量:83
  • 3刘力立,高血压[M].北京:人民卫生出版社,2003:988-1002. 被引量:4
  • 4中国高血压防治指南修订委员会.中国高血压防治指南[M].北京:人民卫生出版社,2005.10. 被引量:127
  • 5中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华血管病杂志,2011,19(8):701-743. 被引量:1
  • 6Dahlof B, Sever PS, Poulter NR, et al. Prevention of eardiovascular events with an anfihypertensive regimen of amlodipine adding per- indopril as required versus atenolol addingbendrolumethiazide as re- quired, in the Anglo-Scandinavian Cardiac Outcomes Trial. Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial [J]. Lancet, 2005, 366(9489): 895-906. 被引量:1
  • 7Webb AJ.Rothwell PM.Physiological correlates of beat-tobeat,ambulatory,.and day-to-day home blood pressure variability after transient ischemic attack or minor stroke.Stroke,2014,45:533-538. 被引量:1
  • 8JennersjO PE,Wijkman M.Wirehn AB.et al.Circadian blood pressure variation in patients with type 2 diabetes-relationship to macro-and microvascular subclinical organ damage.Prim Care Diabetes,2011,5:167-173. 被引量:1
  • 9Krzych TJ,Bochenek A.Blood pressure variability:epidemiological and clinical issues.Cardiol J,2013,20:112-120. 被引量:1
  • 10Rothwel PM,Howard SC,Dolan E,et al.Prognostic significance of visit-to-visit variability,maximum systolic blood pressure,and episodic hypertension.Lancet,2010,375:895-905. 被引量:1

共引文献134

同被引文献27

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部